Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers: The New Tokyo Registry [PDF]
Circulation. Cardiovascular Interventions, 2018 Background: This study assesses clinical outcomes after drug-eluting balloon treatment for recurrent in-stent restenosis lesions based on the number of metallic layers.
H. Yabushita +19 more
semanticscholar +2 more sources
Computational investigation of wall shear stress-driven in-stent restenosis [PDF]
, 2008 C
De Santis, Gianluca
core +3 more sources
Hypersensitivity and in-stent restenosis in coronary stent materials
Frontiers in Bioengineering and Biotechnology, 2022 Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective method for treating CHD.
Wansong Hu, Jun Jiang
semanticscholar +1 more source
Circulation. Cardiovascular Interventions, 2022 Background: Paclitaxel-coated balloons (PCBs) are a preferred treatment option for coronary in-stent restenosis. To date, data from randomized trials of alternative drug coatings are lacking.
B. Scheller +15 more
semanticscholar +1 more source
Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation [PDF]
Folia Medica, 2023 Stent restenosis is the most unfavorable complication of interventional treatment for coronary heart disease. We already know from various literature sources that the causes for stent restenosis in patients are both mechanical damage (partial opening ...
Irina Starodubtseva +2 more
doaj +3 more sources
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes
International Journal of Environmental Research and Public Health, 2021 Diabetes mellitus (DM) is a strong risk factor for the development of cardiovascular diseases such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease (PAD). In the population of people living with DM, PAD is characterised
Grzegorz K. Jakubiak +3 more
semanticscholar +1 more source
BMC Neurology, 2023 Background Prognosis after vertebrobasilar stenting (VBS) may differ from that after carotid artery stenting (CAS). Here, we directly compared the incidence and predictors of in-stent restenosis and stented-territory infarction after VBS and compared ...
Jae-Chan Ryu +10 more
doaj +1 more source
Restenosis begets restenosis: implications for stent selection [PDF]
Netherlands Heart Journal, 2008 Identifying the risk for restenosis is of critical importance in the stent selection process of patients undergoing percutaneous coronary intervention (PCI). Therefore, we sought to determine if a history of clinical recurrence (CR) after PCI increases the risk of CR after treatment of a de novo lesion in another coronary artery.We retrospectively ...
Wijpkema, J. S. +5 more
openaire +3 more sources
Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study
Frontiers in Dental Medicine, 2021 Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue +6 more
doaj +1 more source
Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. [PDF]
, 2006 Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group.
Blindt, Ruediger +5 more
core +2 more sources